Filter posts

New Videos Show How “Fail First” Policies Can Fail Patients

Continued access to a stable treatment can make all the difference for patients with chronic …

Greenwood: A Critical Medicare Policy Has Been Delayed. Let’s Use This Opportunity to Get It Right...

In a piece for Morning Consult, BIO’s Jim Greenwood writes that while CAR-T cell therapies …

A Sustainable Movement to Curb Cancer in Africa

In just two years, BIO Ventures for Global Health (BVGH) has made significant progress in …

FDA Protects Patients While Promoting Innovation

Today, 83 percent of children with cancer survive, compared to just 58 percent in the …

Cancer Surpasses Malaria as Top Public Health Threat in Africa

Africa is known for its diverse cultures, expansive landscapes, dramatic coastlines, luscious forests and exotic …

ICYMI: Drug Development is Complicated. Let’s Start with the Facts.

Here’s a fact you might not have known: 90% of drug development programs fail. Yet …

Oncology Innovation Has Produced Major Drop in Pediatric Cancer Deaths

One of the toughest parts of working in the biotechnology industry is the likelihood that …

California Senate Passed Drug Price Reporting & Transparency Bill

This week the California Senate passed a tremendously flawed bill that would hamper the ability …

ICYMI: Drug Pricing Bill Is Bad for Business, Patients

Researchers and biotech leaders continue to discover new cures and treatments that are making a …

Op-Ed from Cancer Patient Warns: Don’t Sacrifice Cures Through Price Transparency

Deborah Goldberg’s op-ed to The Sacramento Bee recounts her three-year battle with colon cancer. She …